BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee SH, Do SI, Kim HS. Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression. World J Gastroenterol 2014; 20(11): 3011-3017 [PMID: 24659892 DOI: 10.3748/wjg.v20.i11.3011]
URL: https://www.wjgnet.com/1007-9327/full/v20/i11/3011.htm
Number Citing Articles
1
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHBiomarkers in Medicine 2015; 9(11): 1189 doi: 10.2217/bmm.15.70
2
Fengyan Cao, Yunfang Zhang, Weiguang Li, Kuniyoshi Shimizu, Haifeng Xie, Chaofeng Zhang. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathwaysInternational Immunopharmacology 2018; 55: 183 doi: 10.1016/j.intimp.2017.12.023
3
Sedat Per, Mehmet Kose, Ahmet Ozdemir, Dilek Pandir. Hepatoprotective effects of capping protein gelsolin against hyperoxia-induced hepatotoxicity, oxidative stress and DNA damage in neonatal ratsEnvironmental Toxicology and Pharmacology 2018; 58: 189 doi: 10.1016/j.etap.2018.01.007
4
Zhi-Yan Liu, Kai Song, Bin Tu, Li-Chan Lin, He Sun, Yang Zhou, Ji-Ming Sha, Jing-Jing Yang, Ye Zhang, Jian-Yuan Zhao, Hui Tao. Glycolytic reprogramming in organ fibrosis: New dynamics of the epigenetic landscapeFree Radical Biology and Medicine 2023; 207: 1 doi: 10.1016/j.freeradbiomed.2023.07.003
5
Vanille Lejal, Natacha Cerisier, David Rouquié, Olivier Taboureau. Assessment of Drug-Induced Liver Injury through Cell Morphology and Gene Expression AnalysisChemical Research in Toxicology 2023; 36(9): 1456 doi: 10.1021/acs.chemrestox.2c00381
6
Dong Ji, Guo‐Feng Chen, Jin‐Cheng Wang, Li‐Hua Cao, Fengmin Lu, Xiao‐Xin Mu, Xiao‐Yu Zhang, Xiao‐Jie Lu. Identification of TAF1, HNF4A, and CALM2 as potential therapeutic target genes for liver fibrosisJournal of Cellular Physiology 2019; 234(6): 9045 doi: 10.1002/jcp.27579
7
Joseph Leedale, Helen E. Colley, Harriet Gaskell, Dominic P. Williams, Rachel N. Bearon, Amy E. Chadwick, Craig Murdoch, Steven D. Webb. In silico-guided optimisation of oxygen gradients in hepatic spheroidsComputational Toxicology 2019; 12: 100093 doi: 10.1016/j.comtox.2019.100093
8
Haruyo Aoyagi, Hiroko Iijima, Eman S. Gaber, Takuma Zaitsu, Mami Matsuda, Kosho Wakae, Koichi Watashi, Ryosuke Suzuki, Takahiro Masaki, Jeffrey Kahn, Takeshi Saito, Mohamed El‐Kassas, Noritomo Shimada, Keizo Kato, Masaru Enomoto, Kazuhiko Hayashi, Akihito Tsubota, Ayako Mimata, Yuriko Sakamaki, Shizuko Ichinose, Masamichi Muramatsu, Kenjiro Wake, Takaji Wakita, Hideki Aizaki. Hepatocellular organellar abnormalities following elimination of hepatitis C virusLiver International 2023; 43(8): 1677 doi: 10.1111/liv.15624
9
Zhenyu Ma, Lulu Sheng, Juan Li, Jianmin Qian, Gang Wu, Zhengxin Wang, Yi Zhang. Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and InflammationInflammation 2022; 45(2): 812 doi: 10.1007/s10753-021-01586-w
10
Jian-Yong Zhuo, Di Lu, Zu-Yuan Lin, Bei-Ni Cen, Xu-Yong Wei, Hai-Yang Xie, Shu-Sen Zheng, Xiao Xu. C C motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cellsHepatobiliary & Pancreatic Diseases International 2020; 19(5): 440 doi: 10.1016/j.hbpd.2019.12.006